Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
about
New therapeutic strategies for the treatment of male lower urinary tract symptomsResearch Findings on Overactive BladderPostmenopausal overactive bladderEffects of α-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis.Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms - outcome from a randomized controlled trial.Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptomsChronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms.Survey and Risk Factors for Lower Urinary Tract Storage Symptoms in Middle-Aged and Older Stroke Patients in Urban China.Urodynamic characteristics of awake rats under retrained versus freely moving condition: Using a novel model.Association between polymorphism of beta3-adrenoceptor gene and overactive bladder.Transurethral resection of the prostate after radiotherapy for prostate cancer: impact on quality of life.Combined treatment with a β3 -adrenergic receptor agonist and a muscarinic receptor antagonist inhibits detrusor overactivity induced by cold stress in spontaneously hypertensive rats.Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.Variation in cardiovascular risk related to individual antimuscarinic drugs used to treat overactive bladder. A cohort study in the UK.Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission.The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
P2860
Q26746138-851727E0-ECA1-4D4B-B797-41BDAFB42233Q26801459-DD69B886-2692-4568-9C29-A75FB08A96FDQ35157329-4EBCEDA2-31F6-4EDF-855E-D0BEE10D8BE4Q35505462-DB77BC87-DE18-45F0-9990-917BB6C50BE9Q36193388-DE0560DD-71AC-4D8D-A6A3-5A8AFC5385DCQ36262124-72FBFFA6-7DB4-4AF0-A4A2-3D7F0BB1AB90Q38262087-90A67551-7C32-4FD1-9B72-6EC4045EF411Q39824341-60E90E99-EE48-41B1-9AFD-E77161455570Q39855134-9AAF1038-CFE4-4D8D-AE29-0F12EB32387EQ45165100-8385E090-9E1F-472A-A766-7839AB0B2FCBQ48080139-8FFB5EC0-8FEA-4727-8775-A72FAF6C458AQ50881227-41529335-E28C-4225-AD41-51C92530B074Q53630970-4FC58B31-D4A8-4E8B-8089-2ACD1C3202EDQ53820501-202E3D2A-18A2-4252-82D5-43E9EB2A7901Q55425879-82A57D28-6D9E-4E72-AB73-45E02138EFABQ55486735-CD3B6624-8037-4AA5-8DA8-C859DFA833D0
P2860
Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Latest treatment for lower uri ...... gents and mechanism of action.
@en
type
label
Latest treatment for lower uri ...... gents and mechanism of action.
@en
prefLabel
Latest treatment for lower uri ...... gents and mechanism of action.
@en
P2860
P356
P1476
Latest treatment for lower uri ...... gents and mechanism of action.
@en
P2093
Osamu Yamaguchi
P2860
P356
10.1111/IJU.12008
P577
2012-11-28T00:00:00Z